文献速递肺栓塞与肺血管病

预测急性肺栓塞早期大出血的原创风险评分:晕厥、贫血、肾功能不全(PE-SARD)出血评分

An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism: The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score.
PubMed 文献 · Chest · 2021-07-02

基于多中心前瞻性注册研究的2754例急性肺栓塞患者,通过事后多变量logistic回归构建预测住院期间大出血的PE-SARD评分。评分由晕厥(+1.5)、贫血(血红蛋白<12 g/dL,+2.5)和肾功能不全(肾小球滤过率<60 mL/min,+1)组成,C指数0.74(95%CI 0.73-0.76),Brier评分0.028,内部bootstrapping结果相似。该评分表现优于VTE-BLEED、RIETE和BACS评分。

要点

  • PE-SARD评分由晕厥、贫血和肾功能不全三项组成,计算简单易用。
  • 评分越高大出血风险越高:低危0.97%、高危8.93%。
  • 该评分对早期大出血的区分能力优于VTE-BLEED、RIETE和BACS评分。

核心结论

  • PE-SARD出血风险评分是一种原创、易用的工具,用于估计急性肺栓塞患者早期大出血风险。

研究设计与样本

  • 多中心前瞻性注册研究,纳入2754例患者,事后多变量logistic回归构建评分。
  • 采用bootstrapping在推导数据集中有放回抽样500次进行内部验证。
  • 将新评分与VTE-BLEED、RIETE和BACS模型进行比较。

主要发现

  • 共发生82例大出血(3.0%;95%CI 2.39%-3.72%)。
  • 多变量回归识别三个预测因子:晕厥(+1.5)、贫血即血红蛋白<12 g/dL(+2.5)、肾功能不全即肾小球滤过率<60 mL/min(+1)。
  • 风险分组:低危(0分)占52.2%(95%CI 50.29%-54.11%),中危(1-2.5分)占35.2%(95%CI 33.39%-37.04%),高危(>2.5分)占12.6%(95%CI 9.30%-16.56%)。
  • 观察到大出血率随风险组升高而增加,从低危组的0.97%(95%CI 0.53%-1.62%)升至高危组的8.93%(95%CI 6.15%-12.44%)。
  • 推导队列C指数0.74(95%CI 0.73-0.76),Brier评分0.028,内部bootstrapping结果相似。

关键数值与推荐

  • PE-SARD评分:晕厥+1.5分;贫血(血红蛋白<12 g/dL)+2.5分;肾功能不全(肾小球滤过率<60 mL/min)+1分。
  • 低危为0分,中危为1-2.5分,高危为>2.5分。
  • PE-SARD评分表现优于VTE-BLEED、RIETE和BACS评分,在出血与未出血患者中均导致较高比例的出血风险重分类。

临床怎么用

  • 可用于急性肺栓塞患者早期大出血风险分层,辅助优化急性期管理决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Improved prediction of the risk of early major bleeding in pulmonary embolism (PE) is needed to optimize acute management. RESEARCH QUESTION: Does a simple scoring system predict early major bleeding in acute PE patients, identifying patients with either high or low probability of early major bleeding? STUDY DESIGN AND METHODS: From a multicenter prospective registry including 2,754 patients, we performed post hoc multivariable logistic regression analysis to build a risk score to predict early (up to hospital discharge) major bleeding events. We validated the endpoint model internally, using bootstrapping in the derivation dataset by sampling with replacement for 500 iterations. Performances of this novel score were compared with that of the VTE-BLEED (Venous Thrombo-Embolism Bleed), RIETE (Registro informatizado de la enfermedad tromboembólica en España; Computerized Registry of Patients with Venous Thromboembolism), and BACS (Bleeding, Age, Cancer, and Syncope) models. RESULTS: Multivariable regression identified three predictors for the occurrence of 82 major bleeds (3.0%; 95% CI, 2.39%-3.72%): Syncope (+1.5); Anemia, defined as hemoglobin <12 g/dL (+2.5); and Renal Dysfunction, defined as glomerular filtration rate <60 mL/min (+1 point) (SARD). The PE-SARD bleeding score was calculated by summing all the components. Overall, 52.2% (95% CI, 50.29%-54.11%) of patients were classified as low bleeding-risk (score, 0 point), 35.2% (95% CI, 33.39%-37.04%) intermediate-risk (score, 1-2.5 points), and 12.6% (95% CI, 9.30%-16.56%) high-risk (score >2.5 points). Observed bleeding rates increased with increasing risk group, from 0.97% (95% CI, 0.53%-1.62%) in the low-risk to 8.93% (95% CI, 6.15%-12.44%) in the high-risk group. C-index was 0.74 (95% CI, 0.73-0.76) and Brier score 0.028 in the derivation cohort. Similar values were calculated from internal bootstrapping. Performance of the PE-SARD score was better than that observed with the VTE-BLEED, RIETE, and BACS scores, leading to a high proportion of bleeding-risk reclassification in patients who bled and those who did not. INTERPRETATION: The PE-SARD bleeding risk score is an original, user-friendly score to estimate risk of early major bleeding in patients with acute PE.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Chopard R, Piazza G, Falvo N, et al. An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism: The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score. Chest. 2021. PMID: 34217683. doi:10.1016/j.chest.2021.06.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。